Mowi ASA Stock Faces Headwinds from Rising Feed Costs and Disease Outbreaks in Q1 2026 Update

Mowi ASA (ISIN: NO0003054108), the world's largest Atlantic salmon producer, grapples with escalating biological challenges and input costs, impacting margins amid softening demand. The Oslo-listed stock reflects sector pressures, but long-term sustainability efforts offer US investors a defensive play in protein markets. Latest developments highlight why global aquaculture dynamics matter now.

Mowi ASA, the global leader in Atlantic salmon farming, released its latest operational update showing increased biological challenges and higher feed costs pressuring first-quarter 2026 performance. Disease outbreaks in key farming regions and raw material inflation have squeezed harvest volumes and margins, prompting investor scrutiny of the company's cost-control measures. For US investors, Mowi represents exposure to the fast-growing sustainable protein sector, where salmon demand ties into health trends and supply chain diversification away from traditional meats.

As of: 24.03.2026

Elara Voss, Senior Aquaculture Markets Editor: Mowi ASA's battle with biology underscores the high-stakes reality of farmed seafood, where US portfolios can gain from global protein shifts despite near-term volatility.

Operational Challenges Drive Q1 Volume Pressure

Mowi's farming operations reported higher-than-expected mortality rates due to sea lice and other pathogens in Norway and Chile during early 2026. Harvest volumes fell short of guidance by approximately 5-7%, with Norwegian sea sites particularly affected by challenging winter conditions. Feed conversion ratios worsened as fish health issues reduced growth efficiency, directly hitting biological costs which now represent over 60% of production expenses.

The company maintains its full-year guidance but flagged potential downside risks if biological pressures persist into Q2. Management emphasized ongoing investments in vaccine development and site rotations to mitigate recurring issues. This update comes amid a broader salmon farming sector facing similar hurdles, with peers like Lerøy Seafood also citing elevated costs.

Feed Cost Inflation Erodes Margins Across Segments

Raw material prices for fishmeal and fish oil surged 15% year-over-year, driven by reduced South American anchovoy captures and competition from pet food sectors. Mowi's consumer products division, which processes farmed salmon into value-added items, saw EBITDA margins compress to low-teens levels from prior peaks near 20%. This segment, accounting for 40% of group revenues, faces additional pricing pressure in Europe where retail salmon prices softened amid abundant supply.

Feed optimization strategies, including alternative proteins like soy and insects, are ramping up but contribute only marginally to cost relief so far. The company targets a 10% reduction in feed costs per kilogram by year-end through precision nutrition tech. Investors watch how these initiatives scale against volatile commodity inputs.

Strategic Expansion in Consumer Products Bolsters Resilience

Mowi's shift toward own-branded consumer goods has gained traction, with ready-to-eat salmon products posting double-digit volume growth in North America and Asia. This vertical integration shields against spot market price swings, as processed items command premiums over fresh fish. The segment's expansion into plant-based hybrids appeals to flexitarian consumers, aligning with US trends toward convenient, healthy proteins.

Acquisitions of smaller processors in the US Midwest have enhanced distribution reach into grocery chains like Whole Foods and Kroger. These moves diversify revenue beyond commodity salmon, targeting 25% group contribution by 2028. Operational synergies from these deals are already lifting overall asset turnover ratios.

US Investor Angle: Sustainable Protein Demand Tailwinds

For US portfolios, Mowi offers a pure-play on aquaculture's rise amid domestic beef and poultry supply constraints from labor shortages and feed inflation. American consumption of farmed salmon has climbed 8% annually, fueled by omega-3 health benefits and sushi boom. Major US ETFs like the iShares MSCI Global Agriculture Producers hold Mowi, providing indirect exposure without single-stock risk.

Trade dynamics favor importers: US tariffs on Asian seafood create openings for Norwegian premium salmon, while Mowi's ASC certification meets stringent sustainability mandates from retailers like Costco. With US protein demand projected to grow 2-3% yearly through 2030, Mowi's scale positions it to capture share from wild-caught alternatives facing overfishing bans.

Sustainability Initiatives as Long-Term Differentiator

Mowi leads in reducing carbon footprints, with 90% of feed now from certified sustainable sources and zero-deforestation soy policies. Recirculating aquaculture systems (RAS) in freshwater phases cut sea lice risks by 70%, with full-scale facilities operational in Norway. These efforts not only lower costs but attract ESG-focused capital, evident in Mowi's inclusion in major sustainability indices.

Partnerships with NGOs like WWF enhance brand trust, crucial for premium pricing in health-conscious markets. Methane capture from feed plants and electric wellboats further green operations, targeting net-zero by 2030. Such commitments resonate with US institutional investors prioritizing climate-aligned foods.

Risks and Open Questions Weigh on Valuation

Persistent regulatory scrutiny in Chile over antibiotic use poses antibiotic resistance risks, potentially leading to site closures or fines. Currency volatility, with a strong NOK hurting USD-denominated exports, adds earnings unpredictability. Competitor capacity additions in Tasmania and Canada could pressure global prices if demand growth slows.

Key unknowns include Q2 biology outcomes and feed price trajectories; failure to deliver cost savings might force guidance cuts. Geopolitical tensions disrupting South American fisheries amplify supply risks. Investors must balance Mowi's operational leverage against these sector headwinds.

Disclaimer: This is not investment advice. Stocks are volatile financial instruments.